BHVN

Biohaven Ltd. BHVN

BHVN
Biohaven Ltd. NTLA
Intellia Therapeutics, Inc. IMNM
Immunome, Inc. ABCL
AbCellera Biologics Inc. VERA
Vera Therapeutics, Inc. ZBIO
Zenas BioPharma, Inc. CLDX
Celldex Therapeutics, Inc. PHVS
Pharvaris N.V. XERS
Xeris Biopharma Holdings, Inc. SION
Sionna Therapeutics, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode BHVN NTLA IMNM ABCL VERA ZBIO CLDX PHVS XERS SION
6M -10.11 % 3.40 % 172.02 % 6.09 % 99.48 % 61.38 % 12.43 % 11.57 % 40.08 % 109.66 %
YTD 9.96 % 28.88 % 9.75 % 21.87 % -4.81 % -42.23 % -4.89 % -3.13 % 0.82 % -0.92 %
1Y -67.06 % 22.25 % 126.01 % 41.22 % 36.60 % 145.75 % 13.57 % 54.05 % 128.70 % 55.40 %
3Y -30.78 % -67.96 % 395.66 % -60.34 % 504.97 % 10.91 % -45.27 % 178.80 % 492.80 % 55.40 %
5Y 63.29 % -85.50 % 66.42 % -90.59 % 302.43 % 10.91 % 46.55 % -11.55 % 37.99 % 55.40 %
10Y 63.29 % -46.29 % 69.89 % -92.90 % 302.43 % 10.91 % -84.63 % -11.55 % -63.35 % 55.40 %
From the beginning 63.29 % -46.29 % 69.89 % -92.90 % 302.43 % 10.91 % -97.07 % -11.55 % -63.35 % 55.40 %

Dividend